Equities

Circio Holding ASA

Circio Holding ASA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NOK)0.818
  • Today's Change0.01 / 1.24%
  • Shares traded244.56k
  • 1 Year change-92.34%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NOK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments2163178
Total Receivables, Net6.77234.75
Total Inventory------
Prepaid expenses(0.9)5.124.46
Other current assets, total1.443.053.50
Total current assets2894191
Property, plant & equipment, net06.282.66
Goodwill, net------
Intangibles, net0.010.02372
Long term investments------
Note receivable - long term------
Other long term assets--0.00--
Total assets28100565
LIABILITIES
Accounts payable3.45118.10
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases1115.998.89
Other current liabilities, total102320
Total current liabilities1244037
Total long term debt05751
Total debt1116360
Deferred income tax--059
Minority interest------
Other liabilities, total------
Total liabilities12498148
SHAREHOLDERS EQUITY
Common stock4.481919
Additional paid-in capital000
Retained earnings (accumulated deficit)(140)(60)369
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total394430
Total equity(96)2.57418
Total liabilities & shareholders' equity28100565
Total common shares outstanding7.786.546.54
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.